Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
Investing.com - Hershey Co (NYSE: HSY) reported third quarter EPS of $2.34, $0.22 worse than the analyst estimate of $2.56. Revenue for the quarter came in at $2.99B versus the consensus estimate of $3.08B.
Guidance
Hershey Co sees FY 2024 EPS of $9.00-$9.10 versus the analyst consensus of $9.40.
Hershey Co's stock price closed at $176.82. It is down -12.25% in the last 3 months and down -6.45% in the last 12 months.
Hershey Co saw 1 positive EPS revisions and 15 negative EPS revisions in the last 90 days. See Hershey Co's stock price’s past reactions to earnings here.
According to InvestingPro, Hershey Co's Financial Health score is "good performance".
Check out Hershey Co's recent earnings performance, and Hershey Co's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar